Potent inhibitory effect of alpha-viniferin on human cytochrome P450

被引:16
作者
Sim, Juhee [1 ]
Jang, Hae Wring [1 ]
Song, Min [1 ]
Kim, Ji Hyang [2 ]
Lee, Seung Ho [2 ]
Lee, Sangkyu [1 ]
机构
[1] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Taegu 702701, South Korea
[2] Yeungnam Univ, Coll Pharm, Kyongsan 712749, South Korea
基金
新加坡国家研究基金会;
关键词
Alpha-viniferin; Cytochrome P450; Inhibition; Interaction; Human liver microsomes; IN-VITRO INHIBITION; DRUG-INTERACTIONS; RESVERATROL; METABOLISM; LIVER; RATS; SYNTHASE; CYP3A; ROOT;
D O I
10.1016/j.fct.2014.04.023
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
alpha-Viniferin isolated from Caragana chamlagu is a trimer of resveratrol, and has several biological activities, which include anti-inflammatory, anti-oxidant, anti-arthritis, and anti-tumor activities. Herb-drug interactions are the source of the most harmful complications in patients coadministered herbal and modern medicines, and are caused by modulation of the activities of drug metabolizing enzymes. Here, the authors investigated the inhibitory effects of alpha-viniferin on the activities of 9 human cytochrome P450 (CYP) isoforms using a cocktail of probe substrates and LC-MS/MS in pooled human liver microsomes (HLMs). alpha-Viniferin strongly inhibited 7 of the 9 CYP isoforms (except CYP2A6 and CYP2E1). Furthermore, alpha-viniferin strongly inhibited CYP2C19-mediated omeprazole 5-hydroxylation and CYP3A4-catalyzed midazolam 1-hydroxylation with IC50 values of 0.93 and 1.2 mu M, respectively. cc-Viniferin strongly inhibited the activities of these two CYPs dose dependently, but not time-dependently. Lineweaver-Burk plots and secondary plots indicated a typical pattern of mix-mode inhibition for CYP2C19 and 3A4. This is the first investigation conducted on the inhibitory effect of alpha-viniferin on CYP2C19 and 3A4 in HLMs to predict a potential herb-drug interaction. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 26 条
[1]  
[Anonymous], 2006, GUIDANCE IND DRUG IN
[2]   A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats [J].
Chi, Ying-Chang ;
Lin, Shiuan-Pey ;
Hou, Yu-Chi .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 263 (03) :315-322
[3]   Resveratrol is a selective human cytochrome P450 1A1 inhibitor [J].
Chun, YJ ;
Kim, MY ;
Guengerich, FP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (01) :20-24
[4]   α-Viniferin Suppresses the Signal Transducer and Activation of Transcription-1 (STAT-1)-Inducible Inflammatory Genes in Interferon-γ-Stimulated Macrophages [J].
Chung, Eun Yong ;
Roh, Eunmiri ;
Kwak, Jeong-Ah ;
Lee, Heun-Sik ;
Lee, Seung Ho ;
Lee, Chong-Kil ;
Han, Sang-Bae ;
Kim, Youngsoo .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 (04) :405-414
[5]  
Chung EY, 2003, PLANTA MED, V69, P710, DOI 10.1055/s-2003-42787
[6]   Drug interaction potential of resveratrol [J].
Detampel, Pascal ;
Beck, Mareike ;
Kraehenbuehl, Stephan ;
Huwyler, Joerg .
DRUG METABOLISM REVIEWS, 2012, 44 (03) :253-265
[7]  
Gibbs MA, 1999, DRUG METAB DISPOS, V27, P180
[8]  
Guengerich F P, 1997, Adv Pharmacol, V43, P7, DOI 10.1016/S1054-3589(08)60200-8
[9]   Cytochrome P450 and chemical toxicology [J].
Guengerich, F. Peter .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (01) :70-83
[10]   The Protective Effect of Resveratrol on Dimethylnitrosamine-Induced Liver Fibrosis in Rats [J].
Hong, Sang-Won ;
Jung, Kyung Hee ;
Zheng, Hong-Mei ;
Lee, Hee-Seung ;
Suh, Jun-Kyu ;
Park, In-Suh ;
Lee, Don-Haeng ;
Hong, Soon-Sun .
ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (04) :601-609